Your browser doesn't support javascript.
loading
A phase II trial of stereotactic body radiotherapy with concurrent anti-PD1 treatment in metastatic melanoma: evaluation of clinical and immunologic response.
De Wolf, Katrien; Kruse, Vibeke; Sundahl, Nora; van Gele, Mireille; Chevolet, Ines; Speeckaert, Reinhart; Brochez, Lieve; Ost, Piet.
Afiliação
  • De Wolf K; Department of Radiation-Oncology, University Hospital Ghent, De pintelaan 185, 9000, Ghent, Belgium. katrien.dewolf@ugent.be.
  • Kruse V; Department of Medical Oncology, University Hospital Ghent, Ghent, Belgium.
  • Sundahl N; Department of Radiation-Oncology, University Hospital Ghent, De pintelaan 185, 9000, Ghent, Belgium.
  • van Gele M; Department of Dermatology, University Hospital Ghent, Ghent, Belgium.
  • Chevolet I; Department of Dermatology, University Hospital Ghent, Ghent, Belgium.
  • Speeckaert R; Department of Dermatology, University Hospital Ghent, Ghent, Belgium.
  • Brochez L; Department of Dermatology, University Hospital Ghent, Ghent, Belgium.
  • Ost P; Department of Radiation-Oncology, University Hospital Ghent, De pintelaan 185, 9000, Ghent, Belgium.
J Transl Med ; 15(1): 21, 2017 01 31.
Article em En | MEDLINE | ID: mdl-28137295

Texto completo: 1 Eixos temáticos: Pesquisa_clinica Base de dados: MEDLINE Assunto principal: Radiocirurgia / Ensaios Clínicos Fase II como Assunto / Receptor de Morte Celular Programada 1 / Melanoma Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Eixos temáticos: Pesquisa_clinica Base de dados: MEDLINE Assunto principal: Radiocirurgia / Ensaios Clínicos Fase II como Assunto / Receptor de Morte Celular Programada 1 / Melanoma Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article